Furthermore, the suppression of SIRT3 expression has been shown to enhance mitochondrial aconitase 2 (ACO2) activity, thereby facilitating mitochondrial citrate synthesis and contributing to the progression of prostate cancer 58. This evidence concerns the gene SIRT3 and prostate carcinoma.